Sanjay V Malhotra Selected Research

1-dodecyl-3-methylimidazolium tetrafluoroborate

1/2010

A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjay V Malhotra Research Topics

Disease

25	Neoplasms (Cancer) 04/2022 - 08/2009
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 03/2012
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 10/2014
2	Leukemia 01/2022 - 01/2010
2	Triple Negative Breast Neoplasms 07/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 04/2021 - 01/2016
2	Lung Neoplasms (Lung Cancer) 02/2021 - 01/2019
2	Disease Progression 01/2021 - 09/2019
2	Squamous Cell Carcinoma of Head and Neck 09/2019 - 01/2019
2	Inflammation (Inflammations) 01/2019 - 06/2011
1	Lymphoma (Lymphomas) 04/2022
1	Kidney Neoplasms (Kidney Cancer) 04/2022
1	Cardiotoxicity 01/2022
1	COVID-19 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Infections 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Neuralgia (Stump Neuralgia) 05/2019
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2013
1	Genomic Instability 02/2013
1	Chromosomal Instability (Chromosome Stability) 02/2013
1	Carcinogenesis 06/2011

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 01/2022 - 09/2010
4	AndrogensIBA 01/2022 - 01/2017
4	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 03/2012
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2018
3	Biological ProductsIBA 11/2021 - 04/2013
3	Androgen Antagonists (Antiandrogens)IBA 01/2019 - 11/2013
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2010
2	imidazoleIBA 07/2021 - 01/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 10/2014
2	Podophyllotoxin (Condylox)FDA LinkGeneric 01/2021 - 09/2019
2	LigandsIBA 01/2019 - 01/2018
2	Ionic LiquidsIBA 01/2010 - 08/2009
1	LipidsIBA 04/2022
1	TubulinIBA 04/2022
1	artemisinin (artemisinine)IBA 01/2022
1	quinolineIBA 01/2022
1	artesunic acidIBA 01/2022
1	entinostat (MS 275)IBA 01/2022
1	nilotinib FDA Link 01/2022
1	ponatinibIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Nucleic AcidsIBA 01/2022
1	PeroxidesIBA 01/2022
1	ArtemisininsIBA 01/2022
1	SaltsIBA 11/2021
1	Oncogene Proteins (Oncogene Protein)IBA 11/2021
1	Peptides (Polypeptides)IBA 11/2021
1	SenotherapeuticsIBA 11/2021
1	indoleIBA 07/2021
1	benzimidazoleIBA 07/2021
1	QuinoxalinesIBA 07/2021
1	PhytochemicalsIBA 04/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021
1	compound 18IBA 02/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Y-Box-Binding Protein 1IBA 01/2021
1	Radiation-Sensitizing AgentsIBA 09/2019
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 05/2019
1	CannabinoidsIBA 05/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	IodidesIBA 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	taxaneIBA 01/2019
1	Investigational DrugsIBA 01/2019
1	trimethylethylammoniumIBA 01/2019
1	Chemokine ReceptorsIBA 01/2019
1	1-(2-thiazolylazo)-2-naphtholIBA 01/2018
1	Small Molecule LibrariesIBA 01/2018
1	tyrosyl-DNA phosphodiesteraseIBA 01/2018
1	Nonsteroidal Anti-AndrogensIBA 01/2017
1	TriazolesIBA 01/2017
1	BromidesIBA 01/2016
1	AlkaloidsIBA 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 10/2014
1	CaspasesIBA 04/2013
1	ellipticineIBA 04/2013
1	DNA (Deoxyribonucleic Acid)IBA 02/2013
1	AntioxidantsIBA 06/2011
1	EnzymesIBA 06/2011
1	NSC 689534IBA 01/2011
1	CopperIBA 01/2011
1	ThiosemicarbazonesIBA 01/2011
1	NucleosidesIBA 09/2010
1	1-dodecyl-3-methylimidazolium tetrafluoroborateIBA 01/2010
1	1-octadecyl-3-methylimidazoliumIBA 01/2010
1	1-dodecyl-3-methylimidazoliumIBA 01/2010

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2016
3	Castration 11/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2019 - 09/2010
1	Radiotherapy 09/2019